Firm of Choice
for the Most Difficult
Legal Issues

Cross-Border Capabilities
with a China Edge



Fangda acts on JW Therapeutics’ HK$2.3 billion Hong Kong listing and global offering


Annual Financial Regulatory Report 2020 Published
The financial sector in China underwent significant change in 2019, as the Chinese government rolled out a series of policies to reform the sector...

Awards & Rankings

Chambers & Partners Asia-Pacific China Awards 2020
Finance Law Firm of the Year

Chambers & Partners Global Guide 2020

Tier 1 Rankings